Opportunities to present our products and technologies and also to better understand the needs of healthcare professionals and patients.
Paris, France
Cardiawave will attend EuroPCR 2025.
Paris, France
Cardiawave présente au salon Medintechs 2025 !
Nous sommes ravis d’annoncer notre participation à Medintechs 2025, qui se tiendra du 10 au 12 mars à Paris, avec la prise de parole du Dr Flavien Vincent : “Valvosoft®- Nouvelle approche non-invasive pour traiter la sténose aortique sévère”
Lille, France
Cardiawave a été présente au CHU Healthtech Connexion Day #3, le 2 décembre 2024, au Grand Palais de Lille.
Nous avons été ravis de participer à cet événement qui rassemble les acteurs clés de l’innovation en santé, merci aux organisateurs France Biotech et Conférence des Directeurs Généraux de CHRU pour cette opportunité.
Washington, USA
Professor Hélène Eltchaninoff presented the abstract titled “Valvosoft Non-Invasive Ultrasound Therapy (NIUT) in Patients With Severe Symptomatic Aortic Valve Stenosis: Safety and Performance Study, 6-Months Follow-Up Update” at TCT 2024 in Washington, D.C.
🗓️ Date: Monday, October 28
🕒 Time: 3:10 PM
Taipei, Taiwan
Clara Magnier, PhD student, presented at the ISTU 2024 conference in Taipei (Taiwan).
🔬 Presentation Title: “Transthoracic Ultrasound Propagation Numerical Model for Non-Invasive Cardiac Ultrasound Therapy Planning”
📅 Presentation Date: September 22, at 10:54 AM – 11:04 AM CST [FUS Physics, Modeling and Hardware session]
📍 Location: Taipei International Convention Center
https://istu.org/istu-2024-taipei/
Sintra, Portugal
💹 Cardiawave CEO Olivier Pierron attended the LSI Europe 2024 Summit from September 16th to 20th in Sintra, Portugal. He presented our latest innovations and shared his thoughts on the future of medical technology investment, on September 19th.
This was an incredible opportunity to learn more about our advances in non-invasive ultrasound therapy and to explore investment prospects that would enhance patients care and contribute to the overall aortic stenosis lifetime management.
London, UK
We shared the latest results of Cardiawave’s clinical studies at ESC Congress 2024 in London, in the following presentations :
📊 Dr Marleen Van Wely presented « Safety and quality of life assessment at 6 months follow-up of the Valvosoft pivotal study » – Session : TAVI vs. SAVR: still unresolved question? , on 31 August • 09:00 BST
📊 Prof. Emmanuel Messas presented « Percutaneous shockwave therapy for calcific aortic stenosis : a new kid on the block ? » – Session: Personalising treatment strategies for aortic valve stenosis: matching therapies to patients, 1 September • 18:15 BST
Prague, Czech Republic
🚀 Groundbreaking presentation at the Cardio World Congress 2024 by Dr Danijela Trifunovic entitled “Cerebral safety evaluation using MRI of the Valvosoft® Non-Invasive Ultrasound Therapy for 10 patients with severe symptomatic aortic valve stenosis” awarded with a Certificate of Recognition!
🌟 Dr Trifunovic highlighted the safety & efficacy of the non-invasive ultrasound therapy device, an investigational robotic image guided solution developed by Cardiawave.
👏 We are very thankful to Dr Trifunovic and all study investigators for their support and advocacy to support innovation and address unmet patient clinical need.
📖 Read the full paper here : https://academic.oup.com/ehjcimaging/article/24/7/e108/7158393?login=false
Paris, France
Cardiawave exposante à SantExpo, sur le stand Innovation du fonds FHF, à Portes de Versailles Hall 7, du 21 au 23 mai 2024.
Merci au Fonds FHF pour cette opportunité pour Cardiawave de mettre en lumière sa thérapie innovante non-invasive par ultrasons pour traiter les patients atteints de RAC symptomatique sévère (Rétrécissement Aortique Calcifié)
🌐 Pour en savoir plus : https://www.santexpo.com/espace-innovation
Paris, France
Cardiawave attended EuroPCR 2024, the World-Leading course and annual meeting of interventional cardiovascular medicine organized by EAPCI (European Association of Percutaneous Cardiovascular Interventions) !
🌐 More about EuroPCR here : https://europcr2024.org/
Dublin, Ireland
🚀 Our CEO Olivier Pierron attended the Medtech Strategist’s Innovation Summit in Dublin, on April 16-18, 2024 !
This summit is recognized as the longest running medical technology investment forum in Europe and will be a great opportunity for for Olivier Pierron to present Cardiawave’s latest achievements on its investigational non-invasive ultrasound therapy for patients suffering from severe symptomatic aortic stenosis with its cutting-edge technology to investors and decision makers dedicated to innovation in the medical field.
🌐 More on Medtech Strategist’s Innovation Summit here : https://www.medtechstrategist.com/overview
London, UK
🚀 Our CEO @Olivier Pierron attended the LSX World Congress in London, on April 29-30, 2024 !
✔️This congress had been an opportunity for Cardiawave to share and create partnerships with decision makers from the world’s most innovative biopharma, medtech and healthtech companies.
🌐 More on LSX World Congress here : https://informaconnect.com/lsx-world-congress/
Atlanta, USA
🔬 Cardiawave at ACC.24, in Atlanta, on April 6-8 !
Prof. Eric Van Belle presented « QUALITY OF LIFE ASSESSMENT AT 30-DAYS FOLLOW-UP OF THE VALVOSOFT® PIVOTAL STUDY ON SEVERE AORTIC VALVE STENOSIS PATIENTS », on April 8, 09 :32 AM – 09 :42 AM EDT.
More on ACC.24 here: https://accscientificsession.acc.org/en
Paris, France
🚀Cardiawave a été présente au Salon Global Industrie à Villepinte mercredi 27 mars, le lieu de rencontre de l’ensemble de l’écosystème industriel. Cet évènement est une opportunité de découvrir les dernières innovations technologiques et de créer des partenariats.
Pour en savoir plus : https://global-industrie.com/en/home-visitors
Tel Aviv, Israel
🔬 Cardiawave attended ICI Meeting, on February 25-26!
Prof. Emmanuel Messas presented « 30-days follow-up: safety and performance of the Valvosoft® Pivotal Study », on February 25, 09:18 Jerusalem Standard Time / 08 :18 AM CET.
More about ICI Meeting here : https://icimed.org/
London, UK
Cardiawave attended PCR London Valves congress, on November 19-21!
Prof. Emmanuel Messas presented the latest clinical results of “Valvosoft® FIM Study” regarding our innovative solution for the treatment by non-invasive ultrasound therapy (NIUT) of Calcific Aortic Stenosis, during his presentation entitled “12-month follow-up of the Valvosoft First-In-Man study” in the TAVI – New indications, techniques and devices – Part 2 session from 10:05 to 10:50 on November 20.
Paris, France
Maurice Delplanque attended the Medicen Day event, on Tuesday, September 26. It was a great opportunity for Cardiawave to share its experience, collaborate with French Care actors and industry leaders to drive forward advancements in healthcare.
https://medicen-day-2023.b2match.io/
Thanks to @Medicen for the organization.
Paris, France
Our COO Maurice Delplanque attended the CNRS Roundtable at Vivatech 2023, this Wednesday 14 June at 5:00 PM ! 🚀 This roundtable concerned the presentation of CNRS Rise Up, a new service offer aimed at the 1,400 companies born in CNRS Labs like Cardiawave. We were honored to have been selected to join this roundtable to share our insights in revolutionizing healthcare with the development of our cutting-edge technology for non-invasive ultrasound therapy of calcific aortic stenosis.
https://www.cnrs.fr/fr/cnrsinfo/vivatech-2023-la-programmation-des-innovation-et-prospectives-cnrs-talks
Paris, France
Cardiawave was selected to participate to the Jon DeHaan Foundation Award Competition during EuroPCR Innovators’ Day next week! The Jon DeHaan Foundation provides funding to individuals and companies focused on commercializing innovative developments in cardiovascular medicine; this award would be a great opportunity for Cardiawave to promote the advances and results of its innovative non-invasive ultrasound therapy for the treatment of calcific aortic stenosis. Please join us for our oral presentation on May 15, 2023, during the Jon DeHaan Foundation Award Competition, at Theatre Havane, from 4:30 PM to 5:10 PM CET!
Palais de la Bourse, Lyon, France
Cardiawave participated in the 2nd edition of the #HIFUture symposium, on April 21st, 2023 at the Palais de la Bourse in Lyon, France, dedicated to the ultrasound treatments of tomorrow.
Prof. Emmanuel Messas presented the latest clinical results regarding our innovative solution for the treatment by non-invasive ultrasound therapy (NIUT) of calcific aortic stenosis, during the “Clinical Innovations” session between 3:30PM to 5:30PM.
This event was an opportunity for us to share our experience and discuss with other experts and professionals in the healthcare industry.
Thanks to LabTAU, Inserm U1032 and Hospices Civils de Lyon Civils de Lyon for the organization!
Palais de la Bourse, Lyon, France
Our Ultrasound R&D Lead Engineer Wojciech Kwiecinski presented at the combined 22nd Annual International Symposium on Therapeutic Ultrasound and 6th European Symposium of EUFUS!
This event brings together leading researchers, scientists, and practitioners from around the world to share the latest advances in therapeutic ultrasound. We were honored to have Wojciech present our cutting-edge technology and research alongside some of the most innovative minds in the industry.
Wojciech presented on “Non-invasive focused ultrasound therapy of calcific aortic stenosis: 40 patients, 12-months follow-up of Valvosoft® FIH Studies” on Tuesday April 18th at 2:16 PM (Salle Ampère) in Palais de la Bourse, Place de la Bourse, 69002 in Lyon, France, Salle Ampère.
We would like to express our gratitude to the organizers of the symposium for giving us the opportunity to showcase our work and to share our passion for advancing the field of therapeutic ultrasound.
Cité des Sciences et de l’Industrie, Paris, France
Notre Directeur des Opérations Maurice Delplanque était présent à la 8ème édition de la « Journée start-up innovantes du dispositif médical », organisé par le SNITEM, le Syndicat National de l’Industrie des Technologies Médicales.
Cet événement, qui a eu lieu le mardi 4 avril 2023 à la Cité des Sciences et de l’Industrie, Paris 19e, rassemble les acteurs clés du secteur de la santé pour découvrir et échanger sur les dernières innovations en matière de dispositifs médicaux. Nous y avons rencontré les professionnels de la santé présents et de partager notre vision de l’avenir du domaine de la cardiologie avec notre traitement innovant et non-invasif par ultrasons de la sténose aortique. Cet événement nous a donné l’opportunité d’en apprendre davantage sur les tendances du marché et de rencontrer des acteurs clés de l’industrie.
Nous tenons à remercier le SNITEM pour l’organisation de cet événement, ainsi que toutes les personnes impliquées dans sa préparation.
Ecole de Physique, les Houches, France
Our PhD student Clara Magnier has participated this week to the Winter School on Therapeutic Ultrasound, at the School of Physics of les Houches in France.
Clara presented yesterday (March 23, 2023) the “Optimization of ultrasonic shock waves for the non-invasive heart therapy”, during student presentation. Thanks to Jean-François Aubry (Physmed), Gail ter Haar (Institute of Cancer Research) and Vera Khokhlova (LIMU/CIMU) for the organization !
Palais des Congrès, Paris, France
Cardiawave is attending one of the major European scientific and medical annual symposium JESFC 2023 featuring major medical research breakthroughs.
Leading researchers and clinicians will be discussing the latest evidence-based research.
JESFC provides cardiologists and other cardiovascular healthcare professionals with everything they need to improve patient outcomes.
Prof. Emmanuel Messas HEGP Hôpital Européen Georges-Pompidou (AP-HP, Assistance Publique – Hôpitaux de Paris ) will be the speaker for the ‘Non-invasive treatment of severe symptomatic aortic stenosis with ultrasound’ presentation sponsored by Cardiawave during the session : ‘Thérapeutiques du futur’ on Friday, January 13th, 2023 at 10:20 AM, Room: Amphithéâtre Bleu.
He will present our non-invasive therapy, our device and our latest clinical results.
Thank you SFC – Société Française de Cardiologie and moderators, Dominique BABUTY and Pr Michel S. SLAMA !
Institut Pasteur, Paris, France
Que fait-on des innovations technologiques en santé ?
Arrivent-elles toujours au patient ? Dans quel délai ? Partout en France ?
Benjamin BERTRAND – CEO Cardiawave – co-intervenant de la table ronde à 11h30 sur ” l’echo thérapie, des technologies de moins en moins invasives” à la base de nombreux dispositifs médicaux qui apportent des solutions thérapeutiques nouvelles, qui améliorent la qualité de vie des patients et une réponse au système de soin, en souffrance.
Benjamin partagera son expérience et s’appuiera sur les résultats prometteurs des études cliniques actuellement en cours avec le dispositif médical de thérapie non-invasive par ultrasons, développé par Cardiawave, pour le traitement de la sténose aortique : traitement de patients aujourd’hui sans solution médicale, absence de chirurgie, courte durée d’hospitalisation, réduction des coûts etc.
Pour Benjamin et ses co-intervenants CEO de medtech, il est urgent d’accélérer l’accès des innovations technologiques en santé pour les patients, les médecins et pour la société en général.
Boston, USA
Our CEO, Benjamin Bertrand, attended the TCT 2022 event, in Boston, from September 16-19. It was a good opportunity for Cardiawave to be there!
Paris, France
Cardiawave attended Vivatech 2022 from June 15-18, in Paris Expo Porte de Versailles. Come and meet us at booth J59! Thanks to CNRS for this opportunity.
Online
Cardiawave attended virtually attending the 2022 LSX World Congress.
Dublin, Ireland
Cardiawave attended the Innovation Summit 22 in Dublin, Ireland, by Medtech Strategist. It had been an opportunity to connect with investors and partners.
Paris
Prof. Messas from HEGP (APHP) presented how to treat aortic stenosis with Focused Ultrasound at Académie Nationale de Chirurgie.
Thanks for such an opportunity!
Online
Cardiawave attended the Emerging Medtech Summit 2022 organized by LSI Intelligence.
Online
Our CEO Benjamin Bertrand virtually attended the RESI Conference from January 11–13, 2022.
Online
Online
Online
Cardiawave attended the AHA Scientific Sessions 2021 from November 13-15. Prof. Emmanuel Messas from HEGP presented our Non-Invasive Ultrasound Therapy (NIUT) in Patients With Severe Symptomatic Aortic Valve Stenosis.
Digital edition – Jonathan Halim
Cardiawave attended the TCT event (Cardiovascular Research Foundation) from November 4-6. Dr. Jonathan Halim from Amphia hospital presented our Non-Invasive Ultrasound Therapy (NIUT) in low-flow, low-gradient severe aortic stenosis at session TCT 47 on November 04 at 8:19 AM. It was a real pleasure for us to participate in this event!
Digital edition – Emmanuel Messas
Prof. Emmanuel Messas presented at European Society of Cardiology (August 27-30), a poster regarding updated clinical results of Cardiawave on-going First-In-Human clinical studies.
Digital edition – Emmanuel Messas
Digital edition – Emmanuel Messas
Digital edition – Wojciech Kwiecinski
Digital edition – Emmanuel Messas
Digital edition – Emmanuel Messas
Prof. Emmanuel Messas presented our latest results during ESC Congress 2020 in September 2020, in an abstract entitled « Safety, feasibility and performance of Valvosoft non-invasive ultrasound therapy in patients with severe symptomatic calcific aortic valve stenosis ».
Digital edition – Daniel Suarez
Our R&D Ultrasound Engineer, Daniel Suarez Escudero, presented our FirstInMan study at IEEEIUS 2020, in Thursday 10 September 2020, at 19:30 (UTC+2). Title of the presentation : Non-Invasive Focused Ultrasound Therapy of Calcified AorticStenosis: First-In-Man Study.
Digital edition – Sander Ijsselmuiden
Washington DC – Emmanuel Messas
Tel Aviv – Emmanuel Messas
Philadelphia – Emmanuel Messas
San Francisco – Peter den Heijer